<DOC>
	<DOCNO>NCT00821561</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Nexagon® subject Persistent Epithelial Defects ( PED ) originally cause chemical burn .</brief_summary>
	<brief_title>A Study Investigate Safety Clinical Effect Nexagon® Treat Persistent Epithelial Defects</brief_title>
	<detailed_description />
	<criteria>1 . Male female subject age 18 year . 2 . Subjects able attend followup visit able comply study procedure . 3 . Subjects willing able give write informed consent take part study . 4 . At Day 7 visit subject must corneal epithelial defect persist 7 day 14 day , minimum diameter 2 mm along great axis , show improvement despite conventional treatment tear supplement bandage contact lens . 5 . The original defect cornea must cause either alkaline acidic agent . 1 . Use concomitant ocular medication screen period specify standardized PED treatment regime 2 . Likely require use concomitant ocular medication specify standardized PED treatment regime study followup period 3 . Decrease increase PED 30 % screening period . 4 . Have active lid ocular infectious process sort 5 . Subjects corneal perforation impend corneal perforation 6 . The circumference affect limbal blood vessel ischemia great 75 % circumference 7 . Subjects severe lid abnormality contributory persistence PED inability close lid . 8 . Subjects bilateral PED , small PED long diameter &gt; 2 mm . 9 . Female subject pregnant breastfeeding . F 10 . Subjects history AIDS HIV . 11 . Subjects condition , Investigator 's opinion , would exclude subject participate . 12 . Treatment systemic corticosteroid ( equivalent &gt; 10 mg/day prednisone ) immunosuppressive chemotherapeutic agent within 7 day prior Day 0 , likely receive one therapy study participation 13 . Subjects participate clinical trial within 30 day prior Day 0 . 14 . Diabetics HbA1c great 6.5 % . 15 . Diabetics currently prescribe one oral medication diabetes . 16 . Subjects one distinct PED study eye .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Persistent</keyword>
	<keyword>cornea</keyword>
	<keyword>defect</keyword>
	<keyword>Nexagon</keyword>
	<keyword>Coda</keyword>
</DOC>